Legend Biotech (LEGN) Other Working Capital Changes (2020 - 2025)
Legend Biotech (LEGN) posted Other Working Capital Changes of -$10.3 million for Q3 2025, down 9.3% on a QoQ basis from -$9.5 million in Q2 2025, and up 39.29% year-over-year from -$7.4 million in Q3 2024.
Legend Biotech (LEGN) has 6 years of Other Working Capital Changes data on file, last reported at -$10.3 million in Q3 2025.
- In Q3 2025, Other Working Capital Changes rose 39.29% year-over-year to -$10.3 million; the TTM figure through Sep 2025 stood at -$45.9 million (down 22.34% YoY), while the FY2022 annual figure was -$50.6 million, down 4207.57% from the prior year.
- Other Working Capital Changes slipped to -$10.3 million in Q3 2025, from -$9.5 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $16.1 million in Q2 2021 and bottomed at -$50.6 million in Q4 2022.
- A 5-year average of -$7.5 million and a median of -$5.6 million in 2021 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes surged 121.43% — and 2024, when it tumbled 135244.44%.
- Year by year, Other Working Capital Changes stood at -$3.0 million in 2021, then sank by 1606.47% to -$50.6 million in 2022, then soared by 100.02% to $9000.0 in 2023, then plunged by 189433.33% to -$17.0 million in 2024, then surged by 39.29% to -$10.3 million in 2025.
- The last three Other Working Capital Changes figures came in at -$10.3 million (Q3 2025), -$9.5 million (Q2 2025), and -$9.0 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.35 Mn |
| Sep 30, 2025 | -10.35 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Mar 31, 2025 | -9.04 Mn |
| Mar 31, 2025 | -9.04 Mn |
| Sep 30, 2024 | -17.04 Mn |
| Sep 30, 2024 | -17.04 Mn |
| Jun 30, 2024 | -8.29 Mn |
| Jun 30, 2024 | -8.29 Mn |
| Mar 31, 2024 | -12.18 Mn |
| Mar 31, 2024 | -12.18 Mn |
| Jun 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | -9,000.00 |
| Mar 31, 2023 | -9,000.00 |
| Dec 31, 2022 | -50.61 Mn |
| Dec 31, 2022 | -50.61 Mn |
| Sep 30, 2022 | -40,000.00 |
| Sep 30, 2022 | -40,000.00 |
| Jun 30, 2022 | -42,000.00 |
| Jun 30, 2022 | -42,000.00 |
| Mar 31, 2022 | -40,000.00 |
| Mar 31, 2022 | -40,000.00 |
| Dec 31, 2021 | -2.97 Mn |
| Dec 31, 2021 | -2.97 Mn |
| Sep 30, 2021 | 312,000.00 |
| Sep 30, 2021 | 312,000.00 |
| Jun 30, 2021 | 16.05 Mn |
| Jun 30, 2021 | 16.05 Mn |
| Mar 31, 2021 | -16.96 Mn |
| Mar 31, 2021 | -16.96 Mn |
| Dec 31, 2020 | 3.37 Mn |
| Dec 31, 2020 | 3.37 Mn |
| Sep 30, 2020 | -8.60 Mn |
| Sep 30, 2020 | -8.60 Mn |